Citadel Advisors’s PolyPid PYPD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-257
Closed -$5.37K 15343
2022
Q4
$5.37K Sell
257
-236
-48% -$6.1K ﹤0.01% 14008
2022
Q3
$17K Sell
493
-1,964
-80% -$243K ﹤0.01% 12133
2022
Q2
$342K Buy
2,457
+1,310
+114% +$196K ﹤0.01% 9512
2022
Q1
$188K Buy
+1,147
New +$174K ﹤0.01% 11613

Other funds holding PYPD

Citadel Advisors's PYPD Position: Q2 2026 in Review

Citadel Advisors reduced its PolyPid (PYPD) stake by 27% in Q2 2026, selling an estimated $71.4K and leaving 42,282 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #11906.

Citadel Advisors first reported a position in PYPD in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.65M in Q2 2020. 33 funds tracked by Wall St. Rank hold PYPD as of Q2 2026.

  • Citadel Advisors held 42,282 shares of PolyPid worth $215K as of Q2 2026.
  • Citadel Advisors sold 15,487 PolyPid shares in Q2 2026, an estimated $71.4K.
  • PolyPid made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #11906 holding.
  • Citadel Advisors first reported a position in PolyPid in Q2 2020 and has held it in 12 quarters since.
  • Citadel Advisors's PolyPid position peaked at $1.65M in Q2 2020.
  • 33 funds tracked by Wall St. Rank held PolyPid as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.